All lobbying filings

HEARTFLOW, INC.

Lobbying for HEARTFLOW, INC. · Medical device firm in the cardiology space

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · California · $100,000.00 expenses · posted Jul 21, 2026

Official filing document

Bills named in this filing 5

S 1717
Ensuring Patient Access to Critical Breakthrough Products Act of 2025
HR 5343
Ensuring Patient Access to Critical Breakthrough Products Act
S 1399
Health Tech Investment Act
HR 6197
Health Tech Investment Act
HR 9260
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027

Lobbying activity 1

Medicare/Medicaid

Issues related to physician payments; issues related to Medicare reimbursement; issues related to Medicare reimbursement of AI-enabled technology; Ensuring Patient Access to Critical Breakthrough Products Act (S. 1717/H.R. 5343); Health Tech Investment Act (S. 1399/H.R. 6197); H.R. 9260, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027, issues related to health care, generally.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.